Sahil Adriouch

12PUBLICATIONS
57CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 20, 2026
Methodological guidelines for P2X receptor assays and data interpretation.

|Nov 10, 2025
Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Amal Elhage, Janna H Hadaya, Chloe Sligar

|Jan 11, 2024
Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice.

Catalina Abad, Mélanie Demeules, Charlotte Guillou

|Sep 06, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors.

Helena Costa-Verdera, Carmen Unzu, Erika Valeri

|May 13, 2023
Animal Models for the Investigation of P2X7 Receptors.

Ronald Sluyter, Sahil Adriouch, Stephen J Fuller

|Feb 11, 2023
The Angiogenesis Inhibitor Isthmin-1 (ISM1) Is Overexpressed in Experimental Models of Glomerulopathy and Impairs the Viability of Podocytes.

Virgilia Sahiri, Jonathan Caron, Elena Roger

Pageof 2

Frequent Collaborators

3 joint publications

Pablo Pelegrin

3 joint publications

Ronald Sluyter

2 joint publications

Valérie Vouret-Craviari

1 joint publications

Mario Leutert